CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil.
Since the end of 2014, stock has depreciated by 13.1% representing an annual average growth of -2.78%. In absolute terms, the value of the company fell by USD 13 mil.
At the end of 2019, the firm traded at price to earnings of 14.3x. Over the last five years, this multiple achieved a high of 18.6x in 2015 and a low of -109x in 2018 with an average of -10.2x.
In terms of EV/EBITDA, stock traded at 9.34x at the end of 2019. Since 2014, stock has traded between 8.21x and 22.5x with an average of 12.0x.
You can see all the company’s data at CVS Health profile, or you can download a report on the company in the report section.
Helgi Library 
